ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling

BACKGROUND: Early studies indicated that ASC-J9®, an androgen receptor (AR) degradation enhancer, could suppress the prostate cancer (PCa) progression. Here we found ASC-J9® could also suppress the PCa progression via an AR-independent mechanism, which might involve modulating the tumor suppressor A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Exp Clin Cancer Res
Hlavní autoři: Tian, Hao, Chou, Fu-ju, Tian, Jing, Zhang, Yong, You, Bosen, Huang, Chi-Ping, Yeh, Shuyuan, Niu, Yuanjie, Chang, Chawnshang
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780640/
https://ncbi.nlm.nih.gov/pubmed/33390173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01760-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky